ETON:US
$15.85
-5.879%
Eton Pharmaceuticals Inc.News & Events
Last updated: Jun 9, 2025, 10:31 PM ET
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI(TM) (hydrocortisone) Oral Solution
GlobeNewswire MAY 28, 2025 5:28 PM EDT• KHINDIVI is the first and only FDA-approved hydrocortisone oral solution •...READ ARTICLEEton Pharmaceuticals to Participate at Upcoming Investor Conferences
GlobeNewswire MAY 14, 2025 4:30 PM EDTDEER PARK, Ill., May 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton”...READ ARTICLEEton Pharmaceuticals Reports First Quarter 2025 Financial Results
GlobeNewswire MAY 13, 2025 4:01 PM EDTQ1 2025 revenue of $17.3 million, with product sales of $14.0 million, representing 76% growth ov...READ ARTICLEEton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
GlobeNewswire MAY 1, 2025 4:30 PM EDTDEER PARK, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton”...READ ARTICLEEton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
GlobeNewswire APR 28, 2025 6:50 AM EDT- NDA submitted for the treatment of central diabetes insipidus - - Expected 10-month review; c...READ ARTICLEEton Pharmaceuticals Out-Licenses International Rights to Increlex®
GlobeNewswire APR 1, 2025 7:00 AM EDTDEER PARK, Ill., April 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Etonȁ...READ ARTICLEEton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
GlobeNewswire MAR 18, 2025 6:50 AM EDTManagement to Hold Investor Day Conference Call Today at 10:00am ET Reported record product...READ ARTICLEEton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
GlobeNewswire MAR 14, 2025 6:50 AM EDT- Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence...READ ARTICLEEton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025
GlobeNewswire MAR 4, 2025 6:50 AM ESTDEER PARK, Ill., March 04, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton ...READ ARTICLEEton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules
GlobeNewswire MAR 3, 2025 6:50 AM EST– Eton expects to significantly expand patient access to this critical treatment for ...READ ARTICLE